Fu Z F, Rupprecht C E, Dietzschold B, Saikumar P, Niu H S, Babka I, Wunner W H, Koprowski H
Wistar Institute of Anatomy and Biology, Philadelphia, PA 19104.
Vaccine. 1993;11(9):925-8. doi: 10.1016/0264-410x(93)90379-c.
Successful field oral vaccination and protection against viral diseases have so far been achieved only with live-attenuated or live-recombinant virus vaccines. In this communication, we present data that demonstrate that a glycoprotein derived from recombinant baculovirus-infected insect cells is efficacious as an oral vaccine. The glycoprotein (G) of rabies virus (Evelyn Rokitnicki Abelseth strain) was abundantly expressed in a baculovirus expression system and oral vaccination of racoons with the baculovirus-expressed G protein resulted in the production of rabies virus-neutralizing antibodies and protection against a lethal challenge with a street rabies virus. The potential for using the baculovirus-expressed G protein for oral immunization of wildlife is discussed.
迄今为止,仅通过减毒活疫苗或重组活病毒疫苗才能成功进行野外口服疫苗接种并预防病毒性疾病。在本通讯中,我们展示的数据表明,源自重组杆状病毒感染昆虫细胞的糖蛋白作为口服疫苗是有效的。狂犬病病毒(伊夫林·罗基特尼基·阿贝尔塞斯毒株)的糖蛋白(G)在杆状病毒表达系统中大量表达,用杆状病毒表达的G蛋白对浣熊进行口服疫苗接种后,产生了狂犬病病毒中和抗体,并对街狂犬病毒的致死性攻击起到了保护作用。本文还讨论了使用杆状病毒表达的G蛋白对野生动物进行口服免疫的潜力。